Literature DB >> 22687602

Nasal carriage of Streptococcus pneumoniae serotypes and Staphylococcus aureus in Streptococcus pneumoniae-vaccinated and non-vaccinated young children.

N H T M Dukers-Muijrers1, E Stobberingh2, P Beisser2, R C H Boesten1, P Jacobs3, C J P A Hoebe1.   

Abstract

Since the implementation of Streptococcus pneumoniae (SPn) conjugate vaccination (PCV), non-vaccine types have prevailed in invasive pneumococcal disease (IPD), and an increase in Staphylococcus aureus (SA) burden has been suggested. Here, we assess the epidemiology of SA and SPn nasal carriage in 620 children at day-care centres; 141 of these children had received 1-4 PCV7 doses. A higher vaccine dosage was associated with non-vaccine-type SPn carriage. Of all SPn isolates, 45% were PCV7 types, 1% were additional PCV10 types and 22% were the three additional PCV13 types. SA carriage was inversely associated with vaccine-type SPn carriage. SPn serotype 19A showed higher SA co-carriage rates compared to other SPn serotypes. PCV7 implementation does not prevent children from being part of the IPD-related SPn transmission chain. These results contribute to the monitoring of SA- and SPn-related disease and add to the debate on the current national vaccination policy that recently included a change from PCV7 to PCV10.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22687602      PMCID: PMC9151902          DOI: 10.1017/S095026881200115X

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   4.434


  33 in total

1.  Colonisation by Streptococcus pneumoniae and Staphylococcus aureus in healthy children.

Authors:  D Bogaert; A van Belkum; M Sluijter; A Luijendijk; R de Groot; H C Rümke; H A Verbrugh; P W M Hermans
Journal:  Lancet       Date:  2004-06-05       Impact factor: 79.321

2.  Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than 5 years of age for prevention of pneumonia: updated analysis using World Health Organization standardized interpretation of chest radiographs.

Authors:  John Hansen; Steven Black; Henry Shinefield; Thomas Cherian; Jane Benson; Bruce Fireman; Edwin Lewis; Paula Ray; Janelle Lee
Journal:  Pediatr Infect Dis J       Date:  2006-09       Impact factor: 2.129

3.  The inverse correlation between Staphylococcus aureus and Streptococcus pneumoniae colonization in infants is not explained by differences in serum antibody levels in the Generation R Study.

Authors:  Ankie Lebon; Nelianne J Verkaik; Corné P de Vogel; Herbert Hooijkaas; Henri A Verbrugh; Willem J B van Wamel; Vincent W V Jaddoe; Albert Hofman; Peter W M Hermans; Tim J Mitchell; Henriette A Moll; Alex van Belkum
Journal:  Clin Vaccine Immunol       Date:  2010-11-17

Review 4.  Advances in pneumococcal disease prevention: 13-valent pneumococcal conjugate vaccine for infants and children.

Authors:  Peter R Paradiso
Journal:  Clin Infect Dis       Date:  2011-05       Impact factor: 9.079

5.  Pneumococcal conjugate vaccination and nasopharyngeal acquisition of pneumococcal serotype 19A strains.

Authors:  Elske J M van Gils; Reinier H Veenhoven; Eelko Hak; Gerwin D Rodenburg; Wendy C M Keijzers; Debby Bogaert; Krzysztof Trzcinski; Jacob P Bruin; Loek van Alphen; Arie van der Ende; Elisabeth A M Sanders
Journal:  JAMA       Date:  2010-09-08       Impact factor: 56.272

Review 6.  Association of serotype with risk of death due to pneumococcal pneumonia: a meta-analysis.

Authors:  Daniel M Weinberger; Zitta B Harboe; Elisabeth A M Sanders; Moses Ndiritu; Keith P Klugman; Simon Rückinger; Ron Dagan; Richard Adegbola; Felicity Cutts; Hope L Johnson; Katherine L O'Brien; J Anthony Scott; Marc Lipsitch
Journal:  Clin Infect Dis       Date:  2010-09-15       Impact factor: 9.079

7.  Epidemiology of Streptococcus pneumoniae and Staphylococcus aureus colonization in healthy Venezuelan children.

Authors:  B Quintero; M Araque; C van der Gaast-de Jongh; F Escalona; M Correa; S Morillo-Puente; S Vielma; P W M Hermans
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-08-30       Impact factor: 3.267

8.  Efficacy of an 11-valent pneumococcal conjugate vaccine against radiologically confirmed pneumonia among children less than 2 years of age in the Philippines: a randomized, double-blind, placebo-controlled trial.

Authors:  Marilla G Lucero; Hanna Nohynek; Gail Williams; Veronica Tallo; Eric A F Simões; Socorro Lupisan; Diozele Sanvictores; Simon Forsyth; Taneli Puumalainen; Juanita Ugpo; Marites Lechago; Margaret de Campo; Erma Abucejo-Ladesma; Lydia Sombrero; Antti Nissinen; Anu Soininen; Petri Ruutu; Ian Riley; Helen P Mäkelä
Journal:  Pediatr Infect Dis J       Date:  2009-06       Impact factor: 2.129

Review 9.  Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates.

Authors:  Katherine L O'Brien; Lara J Wolfson; James P Watt; Emily Henkle; Maria Deloria-Knoll; Natalie McCall; Ellen Lee; Kim Mulholland; Orin S Levine; Thomas Cherian
Journal:  Lancet       Date:  2009-09-12       Impact factor: 79.321

10.  Effect of seven-valent pneumococcal conjugate vaccine on Staphylococcus aureus colonisation in a randomised controlled trial.

Authors:  Elske J M van Gils; Eelko Hak; Reinier H Veenhoven; Gerwin D Rodenburg; Debby Bogaert; Jacob P Bruin; Loek van Alphen; Elisabeth A M Sanders
Journal:  PLoS One       Date:  2011-06-10       Impact factor: 3.240

View more
  6 in total

Review 1.  Staphylococcus aureus and Streptococcus pneumoniae interaction and response to pneumococcal vaccination: Myth or reality?

Authors:  Aylana Reiss-Mandel; Gili Regev-Yochay
Journal:  Hum Vaccin Immunother       Date:  2016       Impact factor: 3.452

2.  Epidemiologic and clinical implications of second-generation pneumococcal conjugate vaccines.

Authors:  Carmen Muñoz-Almagro; Adoracion Navarro-Torne; Roman Pallares
Journal:  Curr Infect Dis Rep       Date:  2013-04       Impact factor: 3.725

3.  Impact of pneumococcal conjugate vaccine on the carriage density of Streptococcus pneumoniae and Staphylococcus aureus in children living with HIV: a nested case-control study.

Authors:  Tila Khan; Ranjan Saurav Das; Bikas K Arya; Amrita Chaudhary; Jyotirmoy Chatterjee; Sangeeta Das Bhattacharya
Journal:  Hum Vaccin Immunother       Date:  2020-01-29       Impact factor: 3.452

4.  Impact of pneumococcal conjugate vaccine on pediatric tympanostomy tube insertion in partial immunized population.

Authors:  Mao-Che Wang; Ying-Piao Wang; Chia-Huei Chu; Tzong-Yang Tu; An-Suey Shiao; Pesus Chou
Journal:  ScientificWorldJournal       Date:  2015-03-09

5.  Prevalence and risk factors for Staphylococcus aureus nasopharyngeal carriage during a PCV trial.

Authors:  Abdoulie Bojang; Lindsay Kendall; Effua Usuf; Uzochukwu Egere; Sarah Mulwa; Martin Antonio; Brian Greenwood; Philip C Hill; Anna Roca
Journal:  BMC Infect Dis       Date:  2017-08-25       Impact factor: 3.090

Review 6.  Interactions of Bacteriophages and Bacteria at the Airway Mucosa: New Insights Into the Pathophysiology of Asthma.

Authors:  Panagiota Tzani-Tzanopoulou; Dimitrios Skliros; Spyridon Megremis; Paraskevi Xepapadaki; Evangelos Andreakos; Nina Chanishvili; Emmanouil Flemetakis; Grigoris Kaltsas; Styliani Taka; Evangelia Lebessi; Anastassios Doudoulakakis; Nikolaos G Papadopoulos
Journal:  Front Allergy       Date:  2021-01-26
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.